Reimbursement turns technology into an accessible service
Insightec said in March 2026 that France had published national reimbursement for unilateral MR-guided focused ultrasound in drug-resistant essential tremor. Concrete tariffs allow hospitals to offer the procedure; reimbursement can matter as much as regulatory approval when expensive treatment otherwise lacks funding.
The decision covers selected patients with moderate-to-severe tremor, requires informed consent and participation in a registry. Access is therefore linked to long-term evidence. French data must assess effectiveness, complications and patient selection, and reimbursement does not mean the method suits everyone.
Ultrasound creates a lesion without an incision
Exablate Neuro converges many low-energy ultrasound beams on a small brain target, raising temperature where they meet and interrupting a tremor circuit. MRI guides the target and temperature while the team tests effects. There is no open skull or implanted electrode, but the brain lesion is irreversible and needs an experienced multidisciplinary team.
Deep brain stimulation is an alternative for some patients, offering adjustable and potentially bilateral treatment but requiring surgery and implant care. Choice should reflect symptoms, anatomy, general health and preference rather than presenting ultrasound as a simple scar-free replacement for every option.
The skull is part of the technical challenge
Bone attenuates and redirects ultrasound, so skull properties are assessed beforehand and not everyone qualifies. Imaging helps planning and correction, and the conscious patient performs clinical tests during treatment. Accuracy comes from preparation and the experience of neurology, neurosurgery, radiology and physics as much as the device.
Adverse effects can affect balance, sensation or speech with differing severity and duration. Patients need realistic probabilities based on independent data and guidance. A French registry can show outcomes beyond selected centres as use widens.
A unilateral procedure answers only part of the clinical question
Tremor often affects both sides, while unilateral treatment targets the dominant or more affected hand. It may greatly improve eating, writing and self-care without removing every symptom. Bilateral intervention has greater safety demands and may have a different regulatory status.
Success should include long-term function, activities, quality of life and possible recurrence, not only a scale immediately after treatment. Registries can reveal differences between centres. The health system must maintain sufficient team volume and expertise rather than fragment an expensive service.
The business model depends on centres and reimbursement
Insightec supports a complex system integrated with MRI, while hospitals invest in equipment, training and theatre time. The tariff needs enough eligible patients for a sustainable centre. Adoption will depend on hospital contracts, scanner compatibility and experienced reference teams, not the size of the theoretical patient population.
Service, consumables and future indications also matter commercially. Research includes Parkinson's disease and opening the blood-brain barrier, but every application needs separate evidence and approval. Success in essential tremor cannot be transferred automatically to experimental uses.
The Czech debate needs data on the full patient pathway
Wider Czech use would require mapping eligible patients, present treatment, MRI capacity and functional-neurosurgery teams, then comparing outcomes, costs, complications and preferences with alternatives. France offers a precedent for registries and centralisation, not an automatically transferable tariff or indication.
Insightec shows how an Israeli medical product may need decades of development, trials and payer negotiation before becoming routine care. Reimbursement is commercially significant, while each patient still needs specialist consultation and realistic selection. The technology removes an incision, not clinical judgement and follow-up.
Sources and editorial note
The Jews.cz editorial team prepared this article from the public materials below, distinguishing company claims, independently documented facts and editorial interpretation.
